COST-EFFECTIVENESS ANALYSIS OF ENOXAPARIN FOR EXTENDED THROMBOPROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) AFTER ELECTIVE TOTAL HIP REPLACEMENT (THR) SURGERY

被引：0
|
作者：
Weitz, J. [1 ]
Bernard, L. [2 ]
Wakeford, C. [3 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Cornerstone Res Grp, Burlington, ON, Canada
[3] Sanofi Aventis, Laval, PQ, Canada
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74637-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A333 / A333
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL HIP AND KNEE REPLACEMENT (THR, TKR) IN CHINESE PATIENTS
    Chen, X. B.
    Eggington, S.
    Wang, C. Y.
    Zhu, M.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A520 - A520
  • [2] Cost-effectiveness of apixaban prophylaxis for venous thromboembolism (VTE) in total knee and hip replacement (TKR/THR)
    Rublee, D.
    Simon, T.
    Migliaccio-Walle, K.
    Merikle, E.
    Caro, J.
    Marchant, N.
    Drost, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 194 - 194
  • [3] Cost-effectiveness of rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA
    Kwong, L.
    Duran, A.
    Diamantopoulos, A.
    Sengupta, N.
    Lees, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 787 - 787
  • [4] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, E.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A40 - A40
  • [5] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN SPAIN
    Diamantopoulos, A.
    Forster, F.
    Brosa, M.
    Lees, M.
    Pinol, C.
    Febrer, L.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A533 - A533
  • [6] The cost-effectiveness of extended venous thromboembolism prophylaxis with enoxaparin versus short-term prophylaxis after elective hip replacement in Poland
    Orlewska, E
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 666 - 667
  • [7] Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
    Caprini, JA
    Arcelus, JL
    Kudrna, JC
    Sehgal, LR
    Oyslender, M
    Maksimovic, D
    MacDougall, A
    [J]. PHLEBOLOGY, 2002, 17 (3-4) : 126 - 133
  • [8] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA
    Chen, X. B.
    Wang, C. Y.
    Eggington, S.
    Zhu, M.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A506 - A506
  • [9] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT OR TOTAL KNEE REPLACEMENT IN COLOMBIA
    Pereira, R.
    Duran, A.
    Lindner, L.
    Toro, W.
    Arango, C. H.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A502 - A502
  • [10] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP AND KNEE REPLACEMENT IN EUROPE
    Monreal, M.
    Ryttberg, L.
    Diamantopoulos, A.
    Lees, M.
    Negrini, C.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 50 - 51
12345